Utility of a Mycobacterium leprae molecular viability assay for clinical leprosy: An analysis of cases from the Philippines, Ethiopia, and Nepal
Shannon M. Lenz, Linda B. Adams(Health Resources and Services Administration), Deanna A. Hagge(Anandaban Hospital), Ruby Thapa(Anandaban Hospital), Tsehaynesh Lema(Armauer Hansen Research Institute), Diana L. Williams(United States Department of Health and Human Services), Ramanuj Lahiri(United States Department of Health and Human Services), Nashone A. Ray(United States Department of Health and Human Services), Jaymes H. Collins(Woman's Hospital), Selfu Girma(Addis Ababa Science and Technology University), Kidist Bobosha(Armauer Hansen Research Institute), David M. Scollard(National Hansen's Disease Program), Marivic Balagon(University of the Philippines Cebu)
Cited by 8
Related Papers
The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans
|Cell|2010|535
Phylogenomics and antimicrobial resistance of the leprosy bacillus Mycobacterium leprae
|Nature Communications|2018|122
New Biomarkers with Relevance to Leprosy Diagnosis Applicable in Areas Hyperendemic for Leprosy
|The Journal of Immunology|2012|85
T-Cell Regulation in Lepromatous Leprosy
|PLoS neglected tropical diseases|2014|84
Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies
|Journal of Immunology Research|2018|78